Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Number of Prior Biologic Disease-modifying Anti-rheumatic Drugs

被引：0
|
作者：
Mease, Philip [1 ]
Lertratanakul, Apinya [2 ]
Strober, Bruce [3 ,4 ]
Tsuji, Shigeyoshi [5 ]
Richette, Pascal [6 ]
Lovan, Charlie [2 ]
Feng, Dai [2 ]
Anderson, Jaclyn K. [2 ]
Van den Bosch, Filip [7 ]
机构：
[1] Seattle Rheumatol Associates PLLC, Seattle, WA USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] Cent Connecticut Dermatol, New Haven, CT USA
[5] Natl Hosp Org, Osaka Minami Med Ctr, Dept Orthopaed Rheumatol, Osaka, Japan
[6] Lariboisiere Hosp, Dept Rheumatol, Paris, France
[7] Ghent Univ Hosp, Ghent, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
INADEQUATE RESPONSE; DOUBLE-BLIND; SAFETY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1356
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Mease, P. J.
    Lertratanakul, A.
    Strober, B.
    Tsuji, S.
    Richette, P.
    Lovan, C.
    Feng, D.
    Anderson, J.
    Van den Bosch, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 788 - 789
  • [2] Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Number of Prior Biologic Disease-modifying Antirheumatic Drugs
    Philip, Mease
    Apinya, Lertratanakul
    Bruce, Strober
    Shigeyoshi, Tsuji
    Pascal, Richette
    Charlie, Lovan
    Dai, Feng
    Jaclyn, Anderson K.
    Filip, van den Bosch
    SWISS MEDICAL WEEKLY, 2021, 151 : S24 - S24
  • [3] IMPACT OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN LIPID PROFILE OF PSORIATIC ARTHRITIS PATIENTS
    Guajardo-Aldaco, Andrea L.
    Galarza-Delgado, Dionicio A.
    Azpiri-Lopez, Jose R.
    Colunga-Pedraza, Iris J.
    Cardenas-de la Garza, Jesus A.
    Arvizu-Rivera, Rosa I.
    Elizondo-Benitez, Maria F.
    Gonzalez-Gonzalez, Valeria
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [4] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [5] REAL-WORLD USAGE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH PSORIATIC ARTHRITIS IN GERMANY
    Song, J.
    Anjohrin, S.
    Abe, C.
    Banefelt, J.
    Rieem, Dun A.
    Picker, N.
    Kromer, D.
    Fuchs, A.
    Hahn, P.
    Welby, S.
    VALUE IN HEALTH, 2023, 26 (12) : S305 - S305
  • [6] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Xerxes Pundole
    Natalia V. Zamora
    Harish Siddhanamatha
    Heather Lin
    Jean Tayar
    Leung Cheuk Hong
    Liang Li
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2020, 39 : 787 - 794
  • [7] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Pundole, Xerxes
    Zamora, Natalia V.
    Siddhanamatha, Harish
    Lin, Heather
    Tayar, Jean
    Hong, Leung Cheuk
    Li, Liang
    Suarez-Almazor, Maria E.
    CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 787 - 794
  • [8] Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts
    Moller, Burkhard
    Scholz, Godehard A.
    Amsler, Jennifer
    Ciurea, Adrian
    Micheroli, Raphael
    Nissen, Michael J.
    Papagiannoulis, Eleftherios
    Blapp, Christoph
    Scherer, Almut
    Yawalkar, Nikhil
    RHEUMATOLOGY, 2024, 63 (06) : 1528 - 1533
  • [9] Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
    Simon, David
    Kleyer, Arnd
    Bayat, Sara
    Tascilar, Koray
    Kampylafka, Eleni
    Meinderink, Timo
    Schuster, Louis
    Petrov, Ramona
    Liphardt, Anna-Maria
    Rech, Juergen
    Schett, Georg
    Hueber, Axel J.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [10] Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
    David Simon
    Arnd Kleyer
    Sara Bayat
    Koray Tascilar
    Eleni Kampylafka
    Timo Meinderink
    Louis Schuster
    Ramona Petrov
    Anna-Maria Liphardt
    Juergen Rech
    Georg Schett
    Axel J. Hueber
    Arthritis Research & Therapy, 21
12345